drugset / Trial / NCT00415883

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

NCT00415883

Phase 1 Completed 40 enrolled Novartis
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess how the body changes the blood level of single dose of valsartan 160 mg tablet Japanese formulation and valsartan 160 mg tablet global formulation under fasting condition in healthy volunteers.

Timeline

Start
2006-07
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Valsartan Small molecule 160 mg

Indications

No indication recorded.